Tyrosine Kinase Receptor Expression in Canine Liposarcoma.

about

Recent translational research into targeted therapy for liposarcoma.Expression of receptor tyrosine kinase targets PDGFR-β, VEGFR2 and KIT in canine transitional cell carcinoma.

P2860

Q39265801-D26E3FC1-7016-491A-BC43-3A27770DC868 Q48104915-6FFFB4B0-BAE4-47AF-8AA4-483E32EAD10A

P2860

Tyrosine Kinase Receptor Expression in Canine Liposarcoma.

Item

http://www.wikidata.org/entity/Q51435849

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Tyrosine Kinase Receptor Expression in Canine Liposarcoma.

@en

Tyrosine Kinase Receptor Expression in Canine Liposarcoma.

@nl

type

Item

label

Tyrosine Kinase Receptor Expression in Canine Liposarcoma.

@en

Tyrosine Kinase Receptor Expression in Canine Liposarcoma.

@nl

prefLabel

Tyrosine Kinase Receptor Expression in Canine Liposarcoma.

@en

Tyrosine Kinase Receptor Expression in Canine Liposarcoma.

@nl

P1476

Tyrosine Kinase Receptor Expression in Canine Liposarcoma

@en

P2093

E Lepri

http://www.w3.org/2001/XMLSchema#string

G Beha

http://www.w3.org/2001/XMLSchema#string

G Sarli

http://www.w3.org/2001/XMLSchema#string

L Crippa

http://www.w3.org/2001/XMLSchema#string

L De Tolla

http://www.w3.org/2001/XMLSchema#string

V Pellegrino

http://www.w3.org/2001/XMLSchema#string

P2860

Thalidomide is an inhibitor of angiogenesis

Paeonol oxime inhibits bFGF-induced angiogenesis and reduces VEGF levels in fibrosarcoma cells

Evaluation of selected growth factor expression in canine spirocercosis (Spirocerca lupi)-associated non-neoplastic nodules and sarcomas.

Antitumor activity of thalidomide in refractory multiple myeloma.

Liposarcomas in dogs: 56 cases (1989-2000).

Prognostic factors for cutaneous and subcutaneous soft tissue sarcomas in dogs.

Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients.

Thalidomid: current role in the treatment of non-plasma cell malignancies.

Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcoma

GIST with a twist--upregulation of PDGF-B resulting in metachronous gastrointestinal stromal tumor and dermatofibrosarcoma protuberans.

P304

212-217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0300985816671379

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Giancarlo Avallone

Paola Roccabianca

P577

2016-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27698080

http://www.w3.org/2001/XMLSchema#string

Tyrosine Kinase Receptor Expression in Canine Liposarcoma.

about

P2860

P2860

Tyrosine Kinase Receptor Expression in Canine Liposarcoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698